November 10, 2023 Generic Drugs Canada must study psychedelic treatment for veteran PTSD ‘immediately’: Senate report. Yes they should and now.
October 27, 2023 Dementia Time Magazine piece on treatment of early Alzheimer’s Disease lacks balance. It reads as an ad for pharma company that made it. Side effects glossed over and relative instead of absolute risk reported. Clinical outcomes overstated.
October 25, 2023 Addiction Study evaluates observational studies to determine ten predictors of opioid overdose in chronic pain patients
October 17, 2023 Addiction New guideline urges doctors to regularly screen for alcohol use disorder. Sure, I’ll add it to the list.
October 11, 2023 Addiction Five years of legal cannabis: fewer charges, many hospitalizations and more than a few questions
October 4, 2023 Mental Health More adults are taking medication for ADHD. Some were likely undiagnosed during childhood whereas others may have been misdiagnosed with ADHD
September 18, 2023 Depression If you like coffee then enjoy. There are hundreds of observational studies leading to headline claims trying to justify its consumption on the basis of good or bad health outcomes. Nature of these studies: they are unable to establish causality.
August 24, 2023 Dementia New diagnostic test for early Alzheimer’s does not prove that you will develop the disease and requires more biomarkers to ensure accuracy.
August 17, 2023 Dementia A plausible biological mechanism is not well elucidated when study suggests long-term use of certain reflux medications is associated with a higher risk of dementia. No proof of causality and is confounded by other life factors
July 21, 2023 Addiction Researchers say modified version of CBD could help reverse fentanyl effects noted in in vitro trials. Much to be done to determine if it will progress to animal models and eventually testing in human trials.